Press release
Molecular Diagnostics Market Expanding at a CAGR of 11.4% by 2031, Driven by Growing Awareness for Personalized Medicine
Molecular Diagnostics Market Size, Share, Growth Analysis, By Product & Service(Reagents & Kits, Instruments, Services & Software), By Test Type(Lab Tests, PoC Tests), By Sample Type(Blood, Serum, & Plasma, Urine), By Technology(Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next- Generation Sequencing, In Situ Hybridization), By Application(Infectious Disease Diagnostics (Hepatitis, HIV, CT/NG, HAI), By Region - Industry Forecast 2024-2031Molecular Diagnostics Market [https://www.skyquestt.com/report/molecular-diagnostics-market] size was valued at USD 14.00 billion in 2022 and is poised to grow from USD 15.60 billion in 2023 to USD 37.00 billion by 2031, growing at a CAGR of 11.4% during the forecast period (2024-2031).
The demand for molecular diagnostics is increasing due to the raising incidences of infectious diseases along with different types of cancer. A rise in the awareness and adoption of personalized medicines, and significant growth in biomarker identification is fueling the growth of the market. With this therapy it is possible to identify the genomic variants that help in detection, diagnosis, sub classification, prognosis, and monitoring the therapy.Molecular diagnostics can be a sensitive but extremely powerful technique. It is extensively used for classifying biologic markers in a genome and proteome by recognizing bacterial genes and analyzing the specific bacterial infection. In the last few years, developments in molecular diagnosis resulted in the development of new technologies like PCR, NGS, microarray. The global molecular diagnostic market is significantly rising with the prevalence of infectious diseases like HIV, hepatitis, cancer, and respiratory infection.
Download a detailed overview:
https://www.skyquestt.com/sample-request/molecular-diagnostics-market
Development of Precision Medicine is Driving the Molecular Diagnostics
Precision medicine emphasizes customizing medical therapies and interventions for every patient depending on their genetic composition, lifestyle, and environmental aspects. Molecular diagnostics plays an important role here by helping in identifying particular biomarkers, genetic mutations, and gene expression patterns. With this information the healthcare practitioners can make informed decisions about each patient. Today, molecular diagnostics has become a crucial component of the drug development procedure. Companion diagnostics are tests that are used for recognizing patients who will respond positively to the treatment curated for them. This therapy helps the pharmaceutical companies to increase the success rate of the clinical trials and streamline the drug development procedure by identifying the ideal candidates.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/molecular-diagnostics-market
Increasing Focus on Less-Invasive Testing Process
With less invasive testing process healthcare providers can detect the infection at its early stages and constantly monitor it, leading to a better treatment result and patient management. Patients also prefer non-invasive or minimal invasive procedures because they are less painful and have short recovery times, resulting in less risks. The aging population is also more susceptible to chronic diseases that need constant monitoring, making less invasive testing beneficial. Molecular diagnostics also allows blood tests that can identify the specific genetic or protein markers related with different diseases. These tests offer useful information without any invasive process, making them more appealing to patients. The increasing demand for less invasive testing processes is creating immense opportunities for the molecular diagnostics market.
* In January 2024, Illumina partnered with Janssen to manufacture a molecular residual disease liquid biopsy test. The company also has plans of developing a cost-efficient whole-genome sequencing multi-cancer test for identifying DNA.
* In November 2023, Co-Diagnostics Inc., got a grant of 8.97 Million from the Bill & Melinda Gates Foundation for developing an innovative tuberculosis test for Co-Dx PCR platform.
* In July 2023, T2 Biosystem was granted the Breakthrough Device designation from the U.S. FDA for C. Auris direct-from-blood molecular test.
* In February 2023, Thermo Fisher Scientific Inc. collaborated with MyLab to acquire RT-PCR kits for multiple infectious diseases.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/molecular-diagnostics-market
The global molecular diagnostics market is growing rapidly because of multiple factors like rising cases of chronic diseases, technological developments, and the customer preference for personalized treatments. Advancements in the DNA sequencing technology, growing applications in oncology, genetic testing, and adoption of companion diagnostics are also influencing the growth of the market. Moreover, collaborations and alliances among key market players along with emphasis on R&D backed by government institutions are fostering the progression in the molecular diagnostics market.
Related Reports:
Digital Twin Market [https://www.skyquestt.com/report/digital-twin-market]
Visit Our Website: https://www.skyquestt.com/
Media Contact
Company Name: Skyquest Technology
Contact Person: Mr. Jagraj Singh
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=molecular-diagnostics-market-expanding-at-a-cagr-of-114-by-2031-driven-by-growing-awareness-for-personalized-medicine]
Phone: +1 351-333-4748
Address:1 Apache Way, Westford,
Country: United States
Website: https://www.skyquestt.com/report/molecular-diagnostics-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Molecular Diagnostics Market Expanding at a CAGR of 11.4% by 2031, Driven by Growing Awareness for Personalized Medicine here
News-ID: 3588927 • Views: …
More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg
Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject.
Essential Platform Features for Effective Online Chemistry Tutoring
Modern chemistry tutoring…

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…

Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by…

Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…
More Releases for Technology
Insurance Technology Market Outlook 2021 | TIA Technology, Patriot Technology So …
Insurance Technology Market has recently added by Qurate Research to its vast repository. This intelligence report includes investigations based on Current scenarios, Historical records, and future predictions. Report includes overview, which interprets value chain structure, industrial environment, regional analysis, applications, market size, and forecast. The report is integrated with imperative insights on the market, which will support the clients to make precise business decisions. The report incorporates data regarding the…
Global Insurance Technology Market 2019 – Top Companies Xchanging, Insurance T …
"Insurance Technology or Insurtech refers to the use of technology innovations designed to squeeze out savings and efficiency from the current insurance industry model. Insurtech is a portmanteau of “insurance” and “technology” that was inspired by the term fintech.”
Global Insurance Technology Market Research Report is a valuable source of insightful data for business strategists. Provides industry Overviews, including Growth Analysis, Past & Future Costs, Revenue, Demand and Supply Data (where…
Insurance Technology Market Analysis By Major Players | Xchanging, Insurance Tec …
The global Insurance Technology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of between 2018 and 2025.
This report studies the Insurance Technology market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and…
Insurance Technology Market – Major Technology Giants in Buzz Again | TIA Tech …
Global Insurance Technology Market Size, Status and Forecast 2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing capital structure of the Global Insurance Technology Market. Some of the key players profiled in the study are Xchanging, Insurance Technology…
Global Insurance Technology Market 2018-2025 Health and Life Insurance By Xchang …
In 2017, the global Insurance Technology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of between 2018 and 2025.
This report studies the Insurance Technology market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges,…
Ultrasonic Technologies Market by Technology (Motor/actuator technology, medical …
The global ultrasonic technologies market provides alteration of processes with the use of oscillating sound of very high frequency. It is expected that the market would grow at a respectable rate as the technology is being widely adopted. Various verticals such as industrial units and healthcare are using ultrasound as it is considered a highly efficient technology. In the healthcare sector, it is used for diagnosis and treatment by minimal…